Concepedia

Chi‐Chi Peng

CP

4

Publications

150

Citations

4

H-Index

2015

Active since

Affiliations

Amgen (United States)(Current)

Chi‐Chi Peng is an author at Amgen (United States) specializing in pharmacotherapy, molecular pharmacology, and drug discovery.

Top concepts

MedicinePharmacologyDrug DiscoveryPharmacotherapyMedicinal ChemistryMolecular Pharmacology

Publications per year

2015–2025

4

Publications

4

Use of Physiologically Based Pharmacokinetic (PBPK) Modeling for Predicting Drug-Food Interactions: an Industry Perspective

Arian Emami Riedmaier, Kevin DeMent, James E. Huckle et al. · The AAPS Journal · 2020 · 93 citations · Full text

Discovery of biaryl carboxylamides as potent RORγ inverse agonists

Jianhua Chao, Istvan Enyedy, Kurt van Vloten et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 37 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Medicine +5

A Novel Plated Hepatocyte Relay Assay (PHRA) for In Vitro Evaluation of Hepatic Metabolic Clearance of Slowly Metabolized Compounds

Chi‐Chi Peng, Utkarsh Doshi, Chandra Prakash et al. · Drug Metabolism Letters · 2016 · 10 citations

From DNA-Encoded Library Screening to <b>AM-9747</b>: An MTA-Cooperative PRMT5 Inhibitor with Potent Oral In Vivo Efficacy

Ian Sarvary, M. Vestergaard, Loris Moretti et al. · Journal of Medicinal Chemistry · 2025 · 10 citations · Full text

Rows per page

1–4 of 4